PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19366795

Cancer Res. 2009 May 1 69 9 3955-62

Download in:

View as

General Info

PMID
19366795